II fattore di trascrizione NF-kB: Ruolo nella patogenesi delle malattie infiammatorie, autoimmuni, neoplastiche e implicazioni terapeutiche

Clinica Terapeutica

Volumn 152, Issue 4, 2001, Pages 249-253

  Giuliani, C ^a   Napolitano, G ^a   Bucci, I ^a   Montani, V ^a   Monaco, Fabrizio ^a  

^a UNIVERSITY OF CHIETI   (Italy)

Author keywords

AP1; Autoimmunity; Inflammation; Neoplastic diseases; NF kB; Transcription factors

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;

AUTOIMMUNE DISEASE; HUMAN; INFLAMMATION; NEOPLASM; PHYSIOLOGY; REVIEW;

AUTOIMMUNE DISEASES; ENGLISH ABSTRACT; HUMAN; INFLAMMATION; NEOPLASMS; NF-KAPPA B;

EID: 0035409876     PISSN: 00099074     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (36)

1. Sen R, Baltimore D: Multiple nuclear factors interact with the immunoglobulin enhancer sequences. Cell 46: 706-716, 1986
2. Baldwin AS: The NF-kB and IkB proteins: new discoveries and insights. Annu Rev Immunol 14: 649-681, 1996
3. Ghosh S, May MJ, Kopp EB: The NF-kB and Re1 proteins: evolutionarily conserved mediators of immune responses. Annu Rev Immunol 16: 225-260, 1998
4. McKay LI, Cidlowski JA: Molecular control of immune/ inflammatory responses: interactions between nuclear factor-kB and steroid receptor-signaling pathways. Endocr Rev 20: 435-459, 1999
5. Taniguchi S-I, Shong M, Giuliani C, et al.: Iodide suppression of major histocompatibility class I gene expression in thyroid cells involves enhancer A and the transcription factor NF-kB. Mol Endocrinol 12: 19-33, 1998
6. Beg AA, Sha WC, Bronson RT, et al.: Embryonic lethality and liver degeneration in mice lacking the Re1A component of NF-kB. Nature 376: 167-170, 1995
7. Weih F, Carrasco D, Durham SK, et al.: Multiorgan inflammation and hematopoietic abnormalities in mice with a targeted disruption of Re1B, a member of the NF-kB/Re1 family. Cell 180: 331-340, 1995
8. Sha WC, Liou H-C, Tuomanen EI, et al.: Targeted disruption of the p50 subunit of NF-kB leads to multifocal defects in immune responses. Cell 80: 321-330, 1995
9. Kontgen F, Grumont RJ, Strasser A, et al.: Mice lacking the c-rel proto-oncogene exhibit defects in lymphocyte proliferation, humoral immunity, and interleukin-2 expression. Genes Dev 9: 1965-1977, 1995
10. Barnes PJ, Karin M: Nuclear factor-kB - a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 336: 1066-1071, 1997
11. Robert C, Kupper TS: Inflammatory skin diseases, T cells, and immune surveillance. N Engl J Med 341: 1817-1828, 1999
12. Barnes PJ, Adcock IM: NF-kB: a pivotal role in asthma and a new target for therapy. Trends Pharmacol Sci 18: 46-50, 1997
13. Klement JF, Rice NR, Car BD, et al.: IkBα deficiency results in a sustained NF-kB response and severe widespread dermatitis in mice. Mol Cell Biol 16: 2341-2349, 1996
14. Kopp E, Gosh S: Inhibition of NF-kB by sodium salicylate and aspirin. Science 265: 956-959, 1994
15. Mukaida N, Morita M, Ishikawa Y, et al.: Novel mechanism of glucocorticoid-mediated gene repression: nuclear factor-kB is target for glucocorticoid-mediated interleukin 8 gene repression. J Biol Chem 269: 13289-13295, 1994
16. Giuliani C, Saji M, Napolitano G, et al.: Hormonal modulation of major histocompatibility complex Class I gene expression involves an enhancer A-binding complex consisting of Fra-2 and the p50 subunit of NF-kB. J Biol Chem 270: 11453-11462, 1995
17. Saji M, Moriarty J, Ban T, et al.: Major histocompatibility complex class I gene expression in rat thyroid cells is regulated by hormones, methimazole, and iodide as well as interferon. J Clin Endocrinol Metab 75: 871-878, 1992
18. Kohn LD, Giuliani C, Montani V, et al.: Antireceptor immunity. In: Rayner DC, Champion BR (eds.): Thyroid autoimmunity, Austin, RG Landes Co, 1995, pp. 115-170
19. Kohn LD, Shimura H, Shimura Y, et al.: The thyrotropin receptor. Vitamins and hormones 50: 287-384, 1995
20. Kohn LD, Ban T, Okajima F, et al.: Cloning and regulation of glycoprotein hormone receptor genes. In: Weintraub BD (ed.): Molecular endocrinology: basic concepts and clinical correlations., New York, Raven Press Ltd, 1995, pp. 133-153
21. Singer DS, Mozes E, Kirshner S, et al.: Role of MHC Class I molecules in autoimmune diseases. Crit Rev Immunol 17: 463-468, 1997
22. Mozes E, Kohn LD, Hakim F, et al.: Resistance of MHC Class I-deficient mice to experimental systemic lupus erythematosus. Science, 261: 91-93, 1993
23. Singer DS, Kohn LD, Zinger H, et al.: Methimazole prevents induction of experimental systemic lupus erythematosus in mice. J Immunol 153: 873-880, 1994
24. Chan C, Gery I, Kohn LD, et al.: Periocular inflammation in mice with experimental systemic lupus erythematosus (SLE): a new experimental blepharitis and its modulation. J Immunol, 154: 4830-4835, 1995
25. Kaltschmidt C, Kaltschmidt B, Lannes-Vieira J, et al.: Transcription factor NF-kB is activated in microglia during experimental autoimmune encephalomyelitis. J Neuroimmunol 55: 99-106, 1994
26. Ray A, Prefontaine KE: Physical association and functional antagonism between the p65 subunit of transcription factor NF-kB and the glucocorticoid receptor. Proc Natl Acad Sci USA 91: 752-756, 1994
27. Scheinman RI, Cogswell P, Lofquist AK, et al.: Role of transcriptional activation of IkBα in mediation of immunosuppression by glucocorticoids. Science 270: 283-286, 1995
28. Auphan N, DiDonato JA, Rosette C, et al.: Immunosuppression by glucocorticoids: inhibition of NF-kB activity through induction of IkB synthesis. Science 270: 286-290, 1995
29. Adcock IM, Lane SJ, Brown CR, et al.: Abnormal glucocorticoid receptor-activator protein 1 interaction in steroid-resistant asthma. J Exp Med 182: 1951-1958, 1995
30. Thakur S, Lin HC, Tseng WT, et al.: Rearrangement and altered expression of the NFkB-2 gene in human cutaneous T-lymphoma cells. Oncogene 9: 2335-2344, 1994
31. Bargou RC, Emmerich F, Krappmann D, et al.: Constitutive Nuclear Factor-kB-Re1A activation is required for proliferation and survival of Hodking's disease tumor cells. J Clin Invest 100: 2961-2969, 1997
32. Beauparlant P, Kwan I, Bitar R, et al.: Disruption of IkBα regulation by antisense RNA expression leads to malignant transformation. Oncogene 9: 3189-3197, 1994
33. Liebowitz D: Epstein-Barr virus and a cellular signaling pathway in lymphomas from immunosuppressed patients. N Engl J Med 338: 1413-1421, 1998
34. Hwang S, Ding A: Activation of NF-kB in murine macrophages by taxol. Cancer Biochem Biophys 14: 265-272, 1995
35. Giuliani C, Napolitano G, Mastino A, et al.: Thymosin-a1 regulates MHC class I expression in FRTL-5 cells. Eur J Immunol 30: 778-786, 2000
36. Wang P, Wu P, Siegel M, et al.: Interleukin-10 inhibits nuclear NF-kB activation in human monocytes: IL-10 and IL-4 suppress cytokine synthesis by different mechanism. J Biol Chem 270: 9558-9563, 1995